MedPath
NMPA Approval

Gemcitabine Hydrochloride for Injection

国药准字H20244269

June 28, 2024

Drug Information

注射用盐酸吉西他滨

注射剂

0.2g(按C₉H₁₁F₂N₃O₄计)

化学药品

June 28, 2024

Company Information

Applicant Company

贵州省贵阳市乌当区东风镇马百路云锦段1号

Manufacturing Company

贵州省贵阳市乌当区东风镇马百路云锦段1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用盐酸吉西他滨 - NMPA 批准文号 | MedPath